NT5E and Alzheimer disease: The expression of CD90 and CD73, considered to be predominant MSC markers, were highest in AD-MSCs 99.9 ± 0.17%/98.6 ± 2.3% and 94 ± 0.5%/87.5 ± 4.4%, respectively.